AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

SitaOD MSR 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview SitaOD MSR 50/500 Tablet

Diabetol Duo 50/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, potentially lowering the risk of stroke or heart attack. Diabetol Duo may be used alone or with other diabetes treatments, and its effectiveness is enhanced by a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and current medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under your physician's guidance. Adherence to your doctor's prescribed diet and exercise plan is crucial for optimal diabetes control. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential risk, especially when combined with insulin or sulfonylurea medications; learn to identify and manage this. This medication isn't suitable for all individuals. Inform your doctor about any history of liver, kidney, or heart conditions, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should consult their physician. Interactions with other medications are possible, so provide a complete medication list to your doctor. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor your kidney function and blood sugar throughout your treatment.

Primary Ingredients of SitaOD MSR 50/500 Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of SitaOD MSR 50/500 Tablet

Managing type 2 diabetes

Major Benefits of SitaOD MSR 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. SitaOD MSR 50/500 Tablets should be administered with a meal.

Common Side effects of SitaOD MSR 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use SitaOD MSR 50/500 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the SitaOD MSR 50/500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How SitaOD MSR 50/500 Tablet works:

SitaOD MSR 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside SitaOD MSR 50/500 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of SitaOD MSR 50/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of SitaOD MSR 50/500 Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use SitaOD MSR 50/500 Tablets cautiously, potentially requiring dosage modification. Consult your physician. The medication is contraindicated for those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of SitaOD MSR 50/500 Tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take SitaOD MSR 50/500 Tablet :

Should you forget to take a SitaOD MSR 50/500 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About SitaOD MSR 50/500 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on SitaOD MSR 50/500 Tablet

SitaOD MSR 50/500 Tablet, a combination of sitagliptin and metformin, treats type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged SitaOD MSR 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
SitaOD MSR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
SitaOD MSR 50/500 Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD MSR 50/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sitagliptin/metformin tablets (like SitaOD MSR 50/500) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called MALA, or metformin-associated lactic acidosis). This risk is increased in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking the medication and seek immediate medical attention.
SitaOD MSR 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
SitaOD MSR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
SitaOD MSR 50/500 Tablet is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD MSR 50/500 Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin tablets (like SitaOD MSR 50/500) can rarely cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This risk is higher in individuals with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these symptoms occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged SitaOD MSR 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
SitaOD MSR 50/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
SitaOD MSR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
SitaOD MSR 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD MSR 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like SitaOD MSR 50/500) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged SitaOD MSR 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
SitaOD MSR 50/500 Tablet
107
MRP 124
13% off